MJBizDaily Newsletter

Get our daily email

More Exclusive Features

Chart: Significant challenges await Iowa’s new medical cannabis program

The financial viability of Iowa’s newly launched medical marijuana program may be in question due to: High licensing fees. A restrictive list of qualifying conditions. Limited buy-in from patients and physicians. Widespread confusion about product availability. While Iowa is considered by many to be a CBD-only state, the launch of MMJ sales through licensed dispensaries […]

Read More

What is ‘marijuana’? Name game limits cannabis entrepreneurs

The old debate about what to call the plant cannabis sativa L. is giving businesses real-world headaches in both new and established marijuana markets. Consider: Iowa allows medical marijuana but calls it something else. Texas restricts medical marijuana so severely that doctors must break the law to use the state’s program. California officials are struggling […]

Read More

Marlboro maker, Cronos join forces in exclusive CA$2.4 billion deal to tap global cannabis opportunities

Altria Group, one of the largest tobacco companies in North America, has agreed to invest 2.4 billion Canadian dollars ($1.8 billion) in Ontario-based cannabis producer Cronos Group – the most significant foray by Big Tobacco into the rapidly growing cannabis industry to date.

Altria also agreed to make Cronos its exclusive partner for international cannabis opportunities.

Read More

Week in Review: Phony CA lab data, Utah gov signs medical marijuana bill & ex-Sweet Leaf execs jailed

The results of hundreds of marijuana lab tests in California are alleged to have been falsified, Utah’s governor signs a compromise medical cannabis bill, and two former executives from MJ retailer Sweet Leaf land in jail. Here’s a closer look at some notable developments in the marijuana industry this week. California lab fallout repercussions The […]

Read More

Key UN summit could lead to international rescheduling of cannabis

A crucial milestone for the global industry could be achieved this week, as the World Health Organization (WHO) presents its findings on cannabis to the Commission on Narcotic Drugs (CND) in Vienna. The CND reconvened its 61st session on Dec. 5. The WHO’s Expert Committee on Drug Dependence (ECDD) held meetings in June and November dedicated to pre-review and review […]

Read More

Aphria fallout: 5 takeaways on the report that sent this cannabis stock plunging

The blows to Aphria’s stock continued Wednesday as the Canadian cannabis giant’s share price tumbled in the wake of a scathing short-seller report. Aphria’s stock (Nasdaq: APHA) closed Wednesday at $4.51 – down more than 25% for the day. The company has been on the defensive since Monday, refuting claims lobbed by short sellers Quintessential […]

Read More